-
2
-
-
72049130805
-
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
-
[2] Jack J, Clifford R, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9(1): 119-28 (2010).
-
(2010)
Lancet Neurol
, vol.9
, Issue.1
, pp. 119-128
-
-
Jack, J.1
Clifford, R.2
Knopman, D.S.3
Jagust, W.J.4
Shaw, L.M.5
Aisen, P.S.6
-
4
-
-
79958792912
-
Clinical amyloid imaging in Alzheimer's disease
-
[4] Herholz K, Ebmeier K. Clinical amyloid imaging in Alzheimer's disease. Lancet Neurol 10(7): 667-70 (2011).
-
(2011)
Lancet Neurol
, vol.10
, Issue.7
, pp. 667-670
-
-
Herholz, K.1
Ebmeier, K.2
-
5
-
-
17844364259
-
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD
-
[5] Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nuc Med Mol Imag 32(4): 486-510 (2005).
-
(2005)
Eur J Nuc Med Mol Imag
, vol.32
, Issue.4
, pp. 486-510
-
-
Mosconi, L.1
-
6
-
-
10744232413
-
Imaging Brain Amyloid in Alzheimer’s Disease with Pittsburgh Compound-B
-
[6] Klunk WE, Engler H, Nordberg A, Wang Y, Blomquist G, Holt DP, et al. Imaging Brain Amyloid in Alzheimer’s Disease with Pittsburgh Compound-B. Ann Neurol 55(3): 306-19 (2004).
-
(2004)
Ann Neurol
, vol.55
, Issue.3
, pp. 306-319
-
-
Klunk, W.E.1
Engler, H.2
Nordberg, A.3
Wang, Y.4
Blomquist, G.5
Holt, D.P.6
-
7
-
-
0038792263
-
Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents
-
[7] Mathis CA, Wang Y, Holt DP, Huang G-F, Debnath ML, Klunk WE. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem 46(13): 2740-54 (2003).
-
(2003)
J Med Chem
, vol.46
, Issue.13
, pp. 2740-2754
-
-
Mathis, C.A.1
Wang, Y.2
Holt, D.P.3
Huang, G.-F.4
Debnath, M.L.5
Klunk, W.E.6
-
8
-
-
43849083580
-
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
-
[8] Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain 131(6): 1630-45 (2008).
-
(2008)
Brain
, vol.131
, Issue.6
, pp. 1630-1645
-
-
Ikonomovic, M.D.1
Klunk, W.E.2
Abrahamson, E.E.3
Mathis, C.A.4
Price, J.C.5
Tsopelas, N.D.6
-
9
-
-
84863869296
-
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloidbeta plaques: A prospective cohort study
-
[9] Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Colemant RE, Doraiswamy PM, et al. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloidbeta plaques: a prospective cohort study. Lancet Neurol 11(8): 669-78 (2012).
-
(2012)
Lancet Neurol
, vol.11
, Issue.8
, pp. 669-678
-
-
Clark, C.M.1
Pontecorvo, M.J.2
Beach, T.G.3
Bedell, B.J.4
Colemant, R.E.5
Doraiswamy, P.M.6
-
10
-
-
0025753852
-
The molecular pathology of Alzheimer’s
-
[10] Selkoe DJ. The molecular pathology of Alzheimer’s. Neuron 6(4): 487-98 (1991).
-
(1991)
Neuron
, vol.6
, Issue.4
, pp. 487-498
-
-
Selkoe, D.J.1
-
11
-
-
49349092320
-
PET imaging of amyloid deposition in patients with mild cognitive impairment
-
[11] Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, et al. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging 29(10): 1456-65 (2008).
-
(2008)
Neurobiol Aging
, vol.29
, Issue.10
, pp. 1456-1465
-
-
Forsberg, A.1
Engler, H.2
Almkvist, O.3
Blomquist, G.4
Hagman, G.5
Wall, A.6
-
12
-
-
66649137729
-
Comparison of 18F-FDG and PiB PET in cognitive impairment
-
[12] Lowe VJ, Kemp BJ, Jack CR, Senjem M, Weigand S, Shiung M, et al. Comparison of 18F-FDG and PiB PET in cognitive impairment. J Nuc Med 50(6): 878-86 (2009).
-
(2009)
J Nuc Med
, vol.50
, Issue.6
, pp. 878-886
-
-
Lowe, V.J.1
Kemp, B.J.2
Jack, C.R.3
Senjem, M.4
Weigand, S.5
Shiung, M.6
-
13
-
-
81355135439
-
Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease
-
[13] Kadir A, Almkvist O, Forsberg A, Wall A, Engler H, Långström B, et al. Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease. Neurobiol Aging 33(1): 198.e1-14 (2012).
-
(2012)
Neurobiol Aging 33(1)
, vol.198
-
-
Kadir, A.1
Almkvist, O.2
Forsberg, A.3
Wall, A.4
Engler, H.5
Långström, B.6
-
14
-
-
33749506795
-
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
-
[14] Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, et al. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain 129(11): 2856-66 (2006).
-
(2006)
Brain
, vol.129
, Issue.11
, pp. 2856-2866
-
-
Engler, H.1
Forsberg, A.2
Almkvist, O.3
Blomquist, G.4
Larsson, E.5
Savitcheva, I.6
-
15
-
-
0036743220
-
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET
-
[15] Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frolich L, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. NeuroImage 17(1): 302-16 (2002).
-
(2002)
Neuroimage
, vol.17
, Issue.1
, pp. 302-316
-
-
Herholz, K.1
Salmon, E.2
Perani, D.3
Baron, J.C.4
Holthoff, V.5
Frolich, L.6
-
16
-
-
45749151056
-
Animal models of Alzheimer's disease and frontotemporal dementia
-
[16] Götz J, Ittner LM. Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci 9(7): 532-44 (2008).
-
(2008)
Nat Rev Neurosci
, vol.9
, Issue.7
, pp. 532-544
-
-
Götz, J.1
Ittner, L.M.2
-
17
-
-
27944471285
-
Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain
-
[17] Klunk WE, Lopresti BJ, Ikonomovic MD, Lefterov IM, Koldamova RP, Abrahamson EE, et al. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain. J Neurosci 25(46): 10598-606 (2005).
-
(2005)
J Neurosci
, vol.25
, Issue.46
, pp. 10598-10606
-
-
Klunk, W.E.1
Lopresti, B.J.2
Ikonomovic, M.D.3
Lefterov, I.M.4
Koldamova, R.P.5
Abrahamson, E.E.6
-
18
-
-
24044535149
-
PET imaging of brain with the β-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer’s disease
-
[18] Toyama H, Ye D, Ichise M, Liow J-S, Cai L, Jacobowitz D, et al. PET imaging of brain with the β-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer’s disease. Eur J Nuc Med Mol Imaging 32(5): 593-600 (2005).
-
(2005)
Eur J Nuc Med Mol Imaging
, vol.32
, Issue.5
, pp. 593-600
-
-
Toyama, H.1
Ye, D.2
Ichise, M.3
Liow, J.-S.4
Cai, L.5
Jacobowitz, D.6
-
19
-
-
35348821915
-
Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography
-
[19] Maeda J, Ji B, Irie T, Tomiyama T, Maruyama M, Okauchi T, et al. Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography. J Neurosci 27(41): 10957-68 (2007).
-
(2007)
J Neurosci
, vol.27
, Issue.41
, pp. 10957-10968
-
-
Maeda, J.1
Ji, B.2
Irie, T.3
Tomiyama, T.4
Maruyama, M.5
Okauchi, T.6
-
20
-
-
84857959777
-
Small-animal PET imaging of amyloid-beta plaques with [11C] PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease
-
[20] Manook A, Yousefi BH, Willuweit A, Platzer S, Reder S, Voss A, et al. Small-animal PET imaging of amyloid-beta plaques with [11C] PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease. PLoS ONE 7(3): e31310 (2012).
-
(2012)
Plos ONE
, vol.7
, Issue.3
-
-
Manook, A.1
Yousefi, B.H.2
Willuweit, A.3
Platzer, S.4
Reder, S.5
Voss, A.6
-
21
-
-
84865590071
-
PET imaging with [18F]AV-45 in an APP/PS1-21 murine model of amyloid plaque deposition
-
[21] Poisnel GG, Dhilly MM, Moustié OO, Delamare JJ, Abbas AA, Guilloteau DD, et al. PET imaging with [18F]AV-45 in an APP/PS1-21 murine model of amyloid plaque deposition. Neurobiol Aging 33(11): 2561-71 (2012).
-
(2012)
Neurobiol Aging
, vol.33
, Issue.11
, pp. 2561-2571
-
-
Poisnel, G.G.1
Dhilly, M.M.2
Moustié, O.O.3
Delamare, J.J.4
Abbas, A.A.5
Guilloteau, D.D.6
-
22
-
-
84879911625
-
Longitudinal Assessment of Cerebral beta-Amyloid Deposition in Mice Overexpressing Swedish Mutant beta-Amyloid Precursor Protein Using 18F-Florbetaben PET
-
[22] Rominger A, Brendel M, Burgold S, Keppler K, Baumann K, Xiong G, et al. Longitudinal Assessment of Cerebral beta-Amyloid Deposition in Mice Overexpressing Swedish Mutant beta-Amyloid Precursor Protein Using 18F-Florbetaben PET. J Nucl Med 54(7): 1127-34 (2013).
-
(2013)
J Nucl Med
, vol.54
, Issue.7
, pp. 1127-1134
-
-
Rominger, A.1
Brendel, M.2
Burgold, S.3
Keppler, K.4
Baumann, K.5
Xiong, G.6
-
23
-
-
84881392145
-
Longitudinal Amyloid Imaging in Mouse Brain with 11C-PIB: Comparison of APP23, Tg2576, and APPswe-PS1dE9 Mouse Models of Alzheimer Disease
-
[23] Snellman A, Lopez-Picon FR, Rokka J, Salmona M, Forloni G, Scheinin M, et al. Longitudinal Amyloid Imaging in Mouse Brain with 11C-PIB: Comparison of APP23, Tg2576, and APPswe-PS1dE9 Mouse Models of Alzheimer Disease. J Nucl Med 54(8): 1434-41 (2013).
-
(2013)
J Nucl Med
, vol.54
, Issue.8
, pp. 1434-1441
-
-
Snellman, A.1
Lopez-Picon, F.R.2
Rokka, J.3
Salmona, M.4
Forloni, G.5
Scheinin, M.6
-
24
-
-
84925581714
-
Longitudinal PET-MRI reveals [beta]-amyloid deposition and rCBF dynamics and connects vascular amyloidosis to quantitative loss of perfusion
-
[24] Maier FC, Wehrl HF, Schmid AM, Mannheim JG, Wiehr S, Lerdkrai C, et al. Longitudinal PET-MRI reveals [beta]-amyloid deposition and rCBF dynamics and connects vascular amyloidosis to quantitative loss of perfusion. Nat Med 20(12): 1485-92 (2014).
-
(2014)
Nat Med
, vol.20
, Issue.12
, pp. 1485-1492
-
-
Maier, F.C.1
Wehrl, H.F.2
Schmid, A.M.3
Mannheim, J.G.4
Wiehr, S.5
Lerdkrai, C.6
-
25
-
-
84858332587
-
Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: Limitations as a translatable model of Alzheimer's disease
-
[25] Luo F, Rustay NR, Ebert U, Hradil VP, Cole TB, Llano DA, et al. Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease. Neurobiol Aging 33(5): 933-44 (2012).
-
(2012)
Neurobiol Aging
, vol.33
, Issue.5
, pp. 933-944
-
-
Luo, F.1
Rustay, N.R.2
Ebert, U.3
Hradil, V.P.4
Cole, T.B.5
Llano, D.A.6
-
26
-
-
84863433664
-
. Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease
-
[26] Poisnel G, Hérard A-S, El Tannir, El Tayara N, Bourrin E, Volk A, Kober F, et al. Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease. Neuorbiol Aging 33(9): 1995-2005 (2012).
-
(2012)
Neuorbiol Aging
, vol.33
, Issue.9
, pp. 1995-2005
-
-
Poisnel, G.1
Hérard, A.-S.2
El, T.3
El Tayara, N.4
Bourrin, E.5
Volk, A.6
Kober, F.7
-
27
-
-
84875821298
-
Jiménez X, et al
-
[27] Rojas S, Herance JR, Gispert JD, Abad S, Torrent É, Jiménez X, et al. In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography. Neurobiol Aging 34(7): 1790-98 (2013).
-
(2013)
Neurobiol Aging
, vol.34
, Issue.7
, pp. 1790-1798
-
-
Rojas, S.1
Herance, J.R.2
Gispert, J.D.3
Abad, S.4
Torrent, É.5
-
28
-
-
67649410208
-
Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer’s disease
-
[28] Kuntner C, Kesner AL, Bauer M, Kremslehner R, Wanek T, Mandler M, et al. Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer’s disease. Mol Imaging Biol 11(4): 236-40 (2009).
-
(2009)
Mol Imaging Biol
, vol.11
, Issue.4
, pp. 236-240
-
-
Kuntner, C.1
Kesner, A.L.2
Bauer, M.3
Kremslehner, R.4
Wanek, T.5
Mandler, M.6
-
29
-
-
84868131284
-
Imaging microglial activation and glucose consumption in a mouse model of Alzheimer's disease
-
[29] Rapic S, Backes H, Viel T, Kummer MP, Monfared P, Neumaier B, et al. Imaging microglial activation and glucose consumption in a mouse model of Alzheimer's disease. Neurobiol Aging 34(1): 351-54 (2012).
-
(2012)
Neurobiol Aging
, vol.34
, Issue.1
, pp. 351-354
-
-
Rapic, S.1
Backes, H.2
Viel, T.3
Kummer, M.P.4
Monfared, P.5
Neumaier, B.6
-
30
-
-
84904038822
-
Early Detection of Cerebral Glucose Uptake Changes in the 5XFAD Mouse
-
[30] Macdonald IR, Debay DR, Reid GA, Leary TP, Jollymore CT, Mawko G, et al. Early Detection of Cerebral Glucose Uptake Changes in the 5XFAD Mouse. Curr Alzheimer Res 11(5): 450-60 (2014).
-
(2014)
Curr Alzheimer Res
, vol.11
, Issue.5
, pp. 450-460
-
-
Macdonald, I.R.1
Debay, D.R.2
Reid, G.A.3
Leary, T.P.4
Jollymore, C.T.5
Mawko, G.6
-
31
-
-
80855156783
-
Abnormal cognition, sleep, EEG and brain metabolism in a novel knock-in Alzheimer mouse, PLB1
-
[31] Platt B, Drever B, Koss D, Stoppelkamp S, Jyoti A, Plano A, et al. Abnormal cognition, sleep, EEG and brain metabolism in a novel knock-in Alzheimer mouse, PLB1. PLoS ONE 6(11): e27068 (2011).
-
(2011)
Plos ONE
, vol.6
, Issue.11
-
-
Platt, B.1
Drever, B.2
Koss, D.3
Stoppelkamp, S.4
Jyoti, A.5
Plano, A.6
-
32
-
-
3142668938
-
Cognitive correlates of Aβ deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes
-
[32] Howlett DR, Richardson JC, Austin A, Parsons AA, Bate ST, Davies DC, et al. Cognitive correlates of Aβ deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes. Brain Res 1017(1-2): 130-36 (2004).
-
(2004)
Brain Res
, vol.1017
, Issue.1-2
, pp. 130-136
-
-
Howlett, D.R.1
Richardson, J.C.2
Austin, A.3
Parsons, A.A.4
Bate, S.T.5
Davies, D.C.6
-
33
-
-
84952650721
-
Investigations of brain glucose utilization in three transgenic mouse strains that develop neuropathological features of Alzheimer's disease
-
[33] Kelley J, Wintmolders C, Bottelbergs A, Waldron A-M, Wyffels L, Czech C, et al. Investigations of brain glucose utilization in three transgenic mouse strains that develop neuropathological features of Alzheimer's disease. Alzheimer's Dement 9(4): P329 (2013).
-
(2013)
Alzheimer's Dement
, vol.9
, Issue.4
-
-
Kelley, J.1
Wintmolders, C.2
Bottelbergs, A.3
Waldron, A.-M.4
Wyffels, L.5
Czech, C.6
-
34
-
-
77956412778
-
GMP-compliant automated synthesis of [18F]AV-45 (Florbetapir F 18) for imaging β-amyloid plaques in human brain
-
[34] Yao C-H, Lin W-L, Weng C-C, Hsiao I-T, Ting Y-S, Yen T-C, et al. GMP-compliant automated synthesis of [18F]AV-45 (Florbetapir F 18) for imaging β-amyloid plaques in human brain. Appl Radiat Isotopes 68(12): 2293-97 (2009).
-
(2009)
Appl Radiat Isotopes
, vol.68
, Issue.12
, pp. 2293-2297
-
-
Yao, C.-H.1
Lin, W.-L.2
Weng, C.-C.3
Hsiao, I.-T.4
Ting, Y.-S.5
Yen, T.-C.6
-
35
-
-
79955782487
-
Effects of administration route, dietary condition, and blood glucose level on kinetics and uptake of 18F-FDG in mice
-
[35] Wong KP, Sha W, Zhang X, Huang SC. Effects of administration route, dietary condition, and blood glucose level on kinetics and uptake of 18F-FDG in mice. J Nucl Med 52(5): 800-07 (2011).
-
(2011)
J Nucl Med
, vol.52
, Issue.5
, pp. 800-807
-
-
Wong, K.P.1
Sha, W.2
Zhang, X.3
Huang, S.C.4
-
36
-
-
64549141924
-
NEMA NU 2-2007 performance measurements of the Siemens Inveon ™ preclinical small animal PET system
-
[36] Kemp BJ, Hruska CB, McFarland AR, Lenox MW, Lowe VJ. NEMA NU 2-2007 performance measurements of the Siemens Inveon ™ preclinical small animal PET system. Phys Med Biol 54(8): 2359-76 (2009).
-
(2009)
Phys Med Biol
, vol.54
, Issue.8
, pp. 2359-2376
-
-
Kemp, B.J.1
Hruska, C.B.2
McFarland, A.R.3
Lenox, M.W.4
Lowe, V.J.5
-
37
-
-
0028700063
-
Accelerated image reconstruction using ordered subsets of projection data
-
[37] Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging 13(4): 601-09 (1994).
-
(1994)
IEEE Trans Med Imaging
, vol.13
, Issue.4
, pp. 601-609
-
-
Hudson, H.M.1
Larkin, R.S.2
-
38
-
-
0031106959
-
Exact and approximate rebinning algorithms for 3-D PET data
-
[38] Defrise M, Kinahan PE, Townsend DW, Michel C, Sibomana M, Newport DF. Exact and approximate rebinning algorithms for 3-D PET data. IEEE Trans Med Imaging 16(2): 145-58 (1997).
-
(1997)
IEEE Trans Med Imaging
, vol.16
, Issue.2
, pp. 145-158
-
-
Defrise, M.1
Kinahan, P.E.2
Townsend, D.W.3
Michel, C.4
Sibomana, M.5
Newport, D.F.6
-
39
-
-
0034244929
-
New, faster, image-based scatter correction for 3D PET
-
[39] Watson CC. New, faster, image-based scatter correction for 3D PET. IEEE Trans Nucl Sci 47(4): 1587-94 (2000).
-
(2000)
IEEE Trans Nucl Sci
, vol.47
, Issue.4
, pp. 1587-1594
-
-
Watson, C.C.1
-
40
-
-
34548713439
-
A novel approach for imaging brain-behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activator
-
[40] Mirrione MM, Schiffer WK, Fowler JS, Alexoff DL, Dewey SL, Tsirka SE. A novel approach for imaging brain-behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activator. NeuroImage 38(1): 34-42 (2007).
-
(2007)
Neuroimage
, vol.38
, Issue.1
, pp. 34-42
-
-
Mirrione, M.M.1
Schiffer, W.K.2
Fowler, J.S.3
Alexoff, D.L.4
Dewey, S.L.5
Tsirka, S.E.6
-
41
-
-
35748982126
-
Aß deposition and related pathology in an APPx PS1 transgenic mouse model of Alzheimer’s disease
-
[41] Howlett DR, Bowler K, Soden PE, Riddell D, Davis JB, Richardson JC, et al. Aß deposition and related pathology in an APPx PS1 transgenic mouse model of Alzheimer’s disease. Histol Histopathol 23(1): 67-76 (2008).
-
(2008)
Histol Histopathol
, vol.23
, Issue.1
, pp. 67-76
-
-
Howlett, D.R.1
Bowler, K.2
Soden, P.E.3
Riddell, D.4
Davis, J.B.5
Richardson, J.C.6
-
42
-
-
84941997343
-
Preclinical Comparison of the Amyloid-β Radioligands [11C]Pittsburgh compound B and [18F]florbetaben in Aged APPPS1-21 and BRI1-42 Mouse Models of Cerebral Amyloidosis
-
[42] Waldron A-M, Verhaeghe J, wyffels L, Schmidt M, Langlois X, Van Der Linden A, et al. Preclinical Comparison of the Amyloid-β Radioligands [11C]Pittsburgh compound B and [18F]florbetaben in Aged APPPS1-21 and BRI1-42 Mouse Models of Cerebral Amyloidosis. Mol Imaging Biol 1-9 (2015).
-
(2015)
Mol Imaging Biol
, pp. 1-9
-
-
Waldron, A.-M.1
Verhaeghe, J.2
Wyffels, L.3
Schmidt, M.4
Langlois, X.5
Van Der Linden, A.6
-
43
-
-
84923804486
-
Cross-Sectional Comparison of Small Animal [18F]-Florbetaben Amyloid-PET between Transgenic AD Mouse Models
-
[43] Brendel M, Jaworska A, Grießinger E, Rötzer C, Burgold S, Gildehaus F-J, et al. Cross-Sectional Comparison of Small Animal [18F]-Florbetaben Amyloid-PET between Transgenic AD Mouse Models. PLoS ONE 10(2): e0116678 (2015).
-
(2015)
Plos ONE
, vol.10
, Issue.2
-
-
Brendel, M.1
Jaworska, A.2
Grießinger, E.3
Rötzer, C.4
Burgold, S.5
Gildehaus, F.-J.6
-
44
-
-
84885709706
-
Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET
-
[44] Brendel M, Delker A, Rötzer C, Böning G, Carlsen J, Cyran C, et al. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET. NeuroImage 84: 843-53 (2014).
-
(2014)
Neuroimage
, vol.84
, pp. 843-853
-
-
Brendel, M.1
Delker, A.2
Rötzer, C.3
Böning, G.4
Carlsen, J.5
Cyran, C.6
-
45
-
-
77955981090
-
Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models
-
[45] Nicholson RM, Kusne Y, Nowak LA, LaFerla FM, Reiman EM, Valla J. Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models. Brain Res 1347: 179-85 (2010).
-
(2010)
Brain Res
, vol.1347
, pp. 179-185
-
-
Nicholson, R.M.1
Kusne, Y.2
Nowak, L.A.3
Laferla, F.M.4
Reiman, E.M.5
Valla, J.6
-
46
-
-
0034616277
-
Tracking Alzheimer's disease in transgenic mice using fluorodeoxyglucose autoradiography
-
[46] Reiman EM, Uecker A, Gonzalez-Lima F, Minear D, Chen K, Callaway NL, et al. Tracking Alzheimer's disease in transgenic mice using fluorodeoxyglucose autoradiography. NeuroReport 11(5): 987-91 (2000).
-
(2000)
Neuroreport
, vol.11
, Issue.5
, pp. 987-991
-
-
Reiman, E.M.1
Uecker, A.2
Gonzalez-Lima, F.3
Minear, D.4
Chen, K.5
Callaway, N.L.6
-
47
-
-
41649097332
-
FDG autoradiography reveals developmental and pathological effects of mutant amyloid in PDAPP transgenic mice
-
[47] Valla J, Gonzalez-Lima F, Reiman EM. FDG autoradiography reveals developmental and pathological effects of mutant amyloid in PDAPP transgenic mice. Int J Develop Neurosci 26(3-4): 253-58 (2008).
-
(2008)
Int J Develop Neurosci
, vol.26
, Issue.3-4
, pp. 253-258
-
-
Valla, J.1
Gonzalez-Lima, F.2
Reiman, E.M.3
-
48
-
-
33749256422
-
Age- and transgene-related changes in regional cerebral metabolism in PSAPP mice
-
[48] Valla J, Schneider L, Reiman EM. Age- and transgene-related changes in regional cerebral metabolism in PSAPP mice. Brain Res 1116(1): 194-200 (2006).
-
(2006)
Brain Res
, vol.1116
, Issue.1
, pp. 194-200
-
-
Valla, J.1
Schneider, L.2
Reiman, E.M.3
-
49
-
-
84891702999
-
Mapping changes in mouse brain metabolism with PET/CT
-
[49] Welch A, Mingarelli M, Riedel G, Platt B. Mapping changes in mouse brain metabolism with PET/CT. J Nucl Med 54(11): 1946-53 (2013).
-
(2013)
J Nucl Med
, vol.54
, Issue.11
, pp. 1946-1953
-
-
Welch, A.1
Mingarelli, M.2
Riedel, G.3
Platt, B.4
-
50
-
-
79957872121
-
Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease
-
[50] Scheff SW, Price DA, Schmitt FA, Scheff MA, Mufson EJ. Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease. J Alzheimer's Dis 24(3): 547-57 (2011).
-
(2011)
J Alzheimer's Dis
, vol.24
, Issue.3
, pp. 547-557
-
-
Scheff, S.W.1
Price, D.A.2
Schmitt, F.A.3
Scheff, M.A.4
Mufson, E.J.5
-
51
-
-
78650698306
-
Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease
-
[51] Kadir A, Marutle A, Gonzalez D, Scholl M, Almkvist O, Mousavi M, et al. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease. Brain 134(1): 301-17 (2010).
-
(2010)
Brain
, vol.134
, Issue.1
, pp. 301-317
-
-
Kadir, A.1
Marutle, A.2
Gonzalez, D.3
Scholl, M.4
Almkvist, O.5
Mousavi, M.6
-
52
-
-
84855369203
-
Evidence for astrocytosis in prodromal alzheimer disease provided by 11c-deuterium-l-deprenyl: A multitracer PET paradigm combining 11C-pittsburgh compound B and 18F-FDG
-
[52] Carter SF, Scholl M, Almkvist O, Wall A, Engler H, Langstrom B, et al. Evidence for astrocytosis in prodromal alzheimer disease provided by 11c-deuterium-l-deprenyl: a multitracer PET paradigm combining 11C-pittsburgh compound B and 18F-FDG. J Nucl Med 53(1): 37-46 (2012).
-
(2012)
J Nucl Med
, vol.53
, Issue.1
, pp. 37-46
-
-
Carter, S.F.1
Scholl, M.2
Almkvist, O.3
Wall, A.4
Engler, H.5
Langstrom, B.6
-
53
-
-
84923558350
-
In Alzheimer's disease, hypometabolism in low-amyloid brain regions may be a functional consequence of pathologies in connected brain regions
-
[53] Klupp E, Förster S, Grimmer T, Tahmassian M, Yakushev I, Sorg C, et al. In Alzheimer's disease, hypometabolism in low-amyloid brain regions may be a functional consequence of pathologies in connected brain regions. Brain Connect 4(5): 371-83 (2014).
-
(2014)
Brain Connect
, vol.4
, Issue.5
, pp. 371-383
-
-
Klupp, E.1
Förster, S.2
Grimmer, T.3
Tahmassian, M.4
Yakushev, I.5
Sorg, C.6
|